Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

PrimaryBid.com Offer

5 Jun 2018 16:46

RNS Number : 4005Q
Microsaic Systems plc
05 June 2018
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF MICROSAIC SYSTEMS PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED ("PRIMARYBID") WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021).

5 June 2018

MICROSAIC SYSTEMS PLC("Microsaic" or the "Company")

PrimaryBid.com Offer

Microsaic Systems plc (AIM: MSYS) the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce a conditional offer for subscription via PrimaryBid (the "PrimaryBid Offer") of the issue and allotment by the Company of up to 20,000,000 new ordinary shares of 0.25p each in the Company ("New Ordinary Shares") at an issue price of 2 pence per New Ordinary Share (the "Issue Price"), being a discount of 11.1 per cent to the closing mid-market price on 4 June 2018, being the last business day prior to this announcement. Completion of the Offer is conditional on the fundraising announced by the Company on 5 June 2018 becoming unconditional in all respects.

The PrimaryBid Offer is conditional on, inter alia, the passing of resolutions authorising the issue of New Ordinary Shares at the Company's General Meeting which is expected to be convened at 10.00 am on 22 June 2018.

The PrimaryBid Offer for eligible retail investors

The Company highly values its retail investor base and is therefore pleased to provide eligible retail and other investors the opportunity to participate in the PrimaryBid Offer by applying through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the www.PrimaryBid.com platform, will be open to individual and institutional investors from 4.46 p.m. on 5 June 2018 to 9.00 p.m. on 5 June 2018. The PrimaryBid Offer may close early if it is oversubscribed.

Potential Investors should note that this offer will only remain open at the latest until 9.00 p.m. tonight.

Subscriptions under the PrimaryBid Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com to all persons who register with PrimaryBid.com) with any investment request over ÂŁ100,000 first requiring consultation with the Company.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through the www.PrimaryBid.com platform. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn (although, as noted above, the PrimaryBid Offer is conditional).

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or call PrimaryBid on +44 (0)20 7491 6519.

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

The PrimaryBid Offer is being fully underwritten by N+1 Singer.

Expected Timetable of Principal Events

Announcement of the PrimaryBid Offer

4.46 p.m. on 5 June 2018

Closing of the PrimaryBid Offer

9.00 p.m. on 5 June 2018

Announcement of the result of the PrimaryBid Offer

7.00 a.m. on 6 June 2018

General Meeting

10.00 a.m. on 22 June 2018

Admission and commencement of dealings in the New Ordinary Shares on AIM

8.00 a.m. on 25 June 2018

Contacts:

Microsaic Systems plc

+44 (0) 1483 751577

Glenn Tracey, CEO

Bevan Metcalf, FD

N+1 Singer (Nominated Adviser & Broker)

+44 (0)20 7496 3000

Shaun Dobson

Liz Yong

PrimaryBid Limited

+44 (0)20 7491 6519

Dave Mutton

IFC Advisory Ltd (Financial PR)

+44 (0)20 3934 6630

Graham Herring

Heather Armstrong

Florence Chandler

Details of the PrimaryBid Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide eligible retail and other investors the opportunity to participate in the PrimaryBid Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.

Eligible retail and other investors may participate in the PrimaryBid Offer of New Ordinary Shares on a first come, first served basis, exclusively through PrimaryBid. There is a minimum subscription of ÂŁ100 per investor under the terms of the PrimaryBid Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com. Any investment request in excess of ÂŁ100,000 will require the Company's consent and may be subject to scale back.

The PrimaryBid Offer is offered under the exemptions against the need for a prospectus allowed under the prospectus rules made in accordance with the EU Prospectus Directive 2003/71/EC in relation to offers of securities to the public and the admission of securities to trading on a regulated market ("Prospectus Rules"). As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The PrimaryBid Offer is not being made into any jurisdiction where it would be unlawful to do so.

For further details of eligibility and how to subscribe to the Offer please refer to the PrimaryBid.com website at www.PrimaryBid.com. The terms and conditions on which the PrimaryBid Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPFMGGVKKLGRZM
Date   Source Headline
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM
30th May 20141:09 pmRNSNotification of Major Interest in Shares
6th May 201411:58 amRNSGRANT OF SHARE OPTIONS
30th Apr 20147:00 amRNSPreliminary Results
28th Apr 201412:33 pmRNSNotification of Major Interest in Shares
23rd Apr 20148:18 amRNSNotification of Major Interest in Shares
17th Apr 20149:19 amRNSHolding(s) in Company
15th Apr 20149:17 amRNSAppointment of Finance Director
14th Apr 20149:42 amRNSRe Agreement
11th Dec 20133:56 pmRNSHolding(s) in Company
21st Oct 20137:00 amRNSFormation of new Scientific Advisory Group
27th Sep 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSAppointment of Chairman
24th Jun 20137:00 amRNSIssue of Equity
4th Jun 20135:08 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSMicrosaic welcomes launch of the IsoleraT Dalton
31st May 201310:28 amRNSHolding(s) in Company
28th May 20132:44 pmRNSHolding(s) in Company
24th May 201311:23 amRNSResults of General Meeting
15th May 201311:23 amRNSResults of Annual General Meeting
7th May 20134:35 pmRNSDistribution of Circular of General Meeting
3rd May 20136:25 pmRNSConditional Placing to Raise up to £4.28 million
22nd Apr 20137:00 amRNSDistribution of Annual Report and Accounts
15th Apr 20137:00 amRNSPreliminary Results
10th Apr 20137:00 amRNSSigning of commercial agreement
15th Mar 20131:05 pmRNSHolding(s) in Company
14th Mar 20139:00 amRNSLaunch New Chip-based Mass Spectrometry Instrument
12th Dec 20129:36 amRNSGrant of Share Options
19th Oct 20124:45 pmRNSDirector/PDMR Shareholding
15th Oct 20122:26 pmRNSDirector/PDMR Shareholding
24th Sep 20127:00 amRNSAppointment of new CEO
24th Sep 20127:00 amRNSInterim Results
4th Sep 201210:00 amRNSAgreement
4th Jul 20129:46 amRNSGrant of Share Options
25th Jun 201210:29 amRNSMicrosaic Wins R&D100 Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.